Presentation of aversive visual images in health communication for changing health behaviour (Intervention Protocol) by Hollands, Gareth et al.
Presentation of aversive visual images in health
communication for changing health behaviour (Protocol)
Hollands GJ, Cameron LD, Crockett RA, Marteau TM
This is a reprint of a Cochrane protocol, prepared and maintained by The Cochrane Collaboration and published in The Cochrane
Library 2011, Issue 4
http://www.thecochranelibrary.com
Presentation of aversive visual images in health communication for changing health behaviour (Protocol)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iPresentation of aversive visual images in health communication for changing health behaviour (Protocol)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Protocol]
Presentation of aversive visual images in health
communication for changing health behaviour
Gareth J Hollands1, Linda D Cameron2, Rachel A Crockett1, Theresa M Marteau1
1Health Psychology Section, King’s College London, London, UK. 2School of Social Sciences, Humanities and Arts, University of
California, Merced, Merced, CA, USA
Contact address: Gareth J Hollands, Health Psychology Section, King’s College London, 5th Floor, Bermondsey Wing, Guy’s Campus,
London, SE1 9RT, UK. gareth.hollands@kcl.ac.uk.
Editorial group: Cochrane Consumers and Communication Group.
Publication status and date: New, published in Issue 4, 2011.
Citation: Hollands GJ, Cameron LD, Crockett RA, Marteau TM. Presentation of aversive visual images in health commu-
nication for changing health behaviour. Cochrane Database of Systematic Reviews 2011, Issue 4. Art. No.: CD009086. DOI:
10.1002/14651858.CD009086.
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary objective
The primary objective of the review is to estimate the extent to which presentation of visual images of potential health risks or adverse
consequences associated with health behaviours may increase or decrease health behaviour such as:
• dietary behaviour;
• physical activity;
• smoking;
• alcohol consumption;
• sun protection behaviour;
• adherence to medical advice or treatment;
• use of health services, e.g. attendance for screening or treatment programmes.
This will be considered in comparison to the impact of communicating information in a way that does not involve showing the
individual such images (such as through purely written or oral communications).
Secondary objective
A secondary objective is to determine the impact of these interventions on the following outcomes (or their moderating role in behaviour
change):
• intention or motivation to change health behaviour;
• knowledge and understanding of the disease, condition, treatment or risk;
• attitudes toward the disease, condition, treatment or health care;
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• perceived severity of the disease or condition;
• perceived susceptibility to the disease or condition;
• self-efficacy (confidence in the ability to change behaviour);
• response efficacy (perceived effectiveness of behaviour change with regard to health);
• emotional response e.g. fear or disgust
• psychological health of the patient, including anxiety, depression, mood, wellbeing;
• acceptability of the intervention.
B A C K G R O U N D
Noncommunicable conditions, principally cardiovascular dis-
eases, diabetes, cancers, and chronic respiratory diseases, ac-
counted for an estimated 35 million deaths in 2005 (60% of all
deaths globally), with approximately 16 million of these deaths
being in people under 70 years of age (WHO 2008). These con-
ditions are strongly related to patterns of behaviour that may be
modifiable. Achieving health behaviour change is both important,
and difficult. To this end, there is an ongoing interest in develop-
ing interventions which encourage behaviour change.
Description of the intervention
One intervention strategy that has received attention in recent
years, particularly in preventive medicine and population health-
care settings, is the use of aversive visual images that graphically
illustrate the potential health risks or adverse consequences asso-
ciated with health behaviour. A key example, applied internation-
ally, is the use of graphic picture warnings on cigarette packaging
designed to stop people smoking. Health promotion campaigns
regularly make use of aversive images, such as a recent mass media
campaign in the UK that showed the damaging unseen effects of
alcohol on internal organs (Department of Health 2010).
As with other social interactions, health communications, even
those centred around the communication of images, rarely operate
on a purely visual level, and may consist of both visual and verbal
stimuli. Thus it may not always make sense to draw a dichotomy
between what are often complementary sources of information,
and in some contexts, the effect of the addition of images to a
given communication is what will be assessed by this review. Even
if communication is predominantly visual in nature, its meaning
may not be transparent, and limited written information may be
added (as is the case with graphic picture warnings on cigarette
packaging).
How the intervention might work
The development and assessment of health behaviour change in-
terventions has traditionally been rooted in models of rational
decision-making which view our actions as reasoned and inten-
tional, requiring conscious control. Numerous models of health-
related decisions and behaviour have been developed that empha-
sise the processes of rational cognitive appraisal of threat and re-
sponse (Ajzen 1991; Rogers 1983; Schwarzer 2001). It follows
from this approach that providing information that allows the re-
cipient to reflect on the appropriate healthy choice may be suf-
ficient to effect change. However, in many behavioural contexts
this has not been borne out. As such, more recently, researchers
have adopted a more comprehensive approach to understanding
behaviour change, with the development of dual-system models
of behaviour (e.g. Gawronski 2006; Strack 2004). Such models
propose two systems of information processing, consisting of the
processes of reflective, reasoned processing mentioned earlier, to-
gether with the processes of learned associations that are outside
of conscious awareness and give rise to behavioural impulses. The
latter are defined by their relation to specific cues in the environ-
ment, and having a strong emotional component, as well as pro-
viding a behavioural urge to act or approach a stimulus.
In questioning the concept of the rational decision-maker oper-
ating on a largely individual basis, we must also consider other
situational and environmental factors which can limit or direct
individuals’ behaviour beyond their immediate conscious control.
For example, socio-economic status has been shown to be a sig-
nificant determinant of health behaviour, such as smoking (Eek
2010). We introduce the potential roles of such non-conscious
processing and environmental influences in behaviour change to
give a sense of the wider theoretical context that may explain the
effects of behavioural interventions. Whilst we will not systemat-
ically assess these factors in the current review, we will consider
them as effect modifiers when contextualising the evidence.
When mainly focusing on conscious, rational processing at the
level of the individual, the mechanisms underlying behaviour
change remain complex. However, they can be conceptualised as
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dependent on two sets of processes: motivational (forming an in-
tention to undertake a given behaviour) and volitional (actually
performing the behaviour) (Schwarzer 2001). Forming an inten-
tion is a moderately strong predictor of behaviour, but is not an
absolute predictor (Webb 2006). Incorporating aversive visual im-
ages as a component of an intervention may enhance the commu-
nication of health risk and health-related information and thus
alter an individual’s motivational processing concerning a recom-
mended action. This may be effective because, as with the process-
ing of emotional information, visual information and its meaning
is thought to be readily assimilated, whilst abstract language re-
quires more analysis (Dansereau 2009). In cognition research, the
’picture superiority effect’ is a well-documented finding: stimuli
presented as images are better remembered on tests of recall or dis-
crimination than equivalent stimuli presented as words (Hockley
2008; Mintzer 1999). Research on the use of visual images for
enhancing health communication is limited, but has shown that
pictures linked to written or spoken text can significantly increase
attention to, recall, and comprehension of health information
(Brotherstone 2006; Houts 2006).
Why it is important to do this review
Using aversive visual images to communicate health information
may hold intuitive appeal and be considered more potent and in-
fluential than non-visual means of communication. This is ever
more so, within a context of the increasing application of visual
imagery in medical science and social communication, and by ex-
tension, where these spheres overlap, in clinical and preventive
healthcare settings. Presently, aversive imagery is included inwarn-
ing messages for smoking cessation internationally, including in
the UK, Canada, Australia, Egypt and Brazil. Ongoing empirical
assessment of the actual efficacy of such interventions in changing
behaviour is therefore of great interest, as is evidence which may
suggest the value of similar approaches in different clinical and be-
havioural contexts. Whilst interventions that focus on providing
information to a relatively passive recipient have typically been as-
sociated with small effects on behaviour change (Albarracin 2005;
Stadler 2010), the opportunity for widespread application means
that there is inherent potential for aggregate impact as a popula-
tion-based strategy.
This review will gather a coherent body of experimental evidence
to examine systematically the behavioural impact of presenting
aversive visual images. Previous reviews of a range of aversive com-
munications (e.g. Witte 2000; de Hoog 2007) whilst comprehen-
sive in scope, have not utilised methods able to adequately deter-
mine this. Furthermore, we will examine the cognitive and emo-
tional mediators and moderators of any behavioural change, and
make recommendations for future research and application. We
are confident that there are now sufficient studies, including sev-
eral in press of which we are aware, to make a review of the area
viable.
O B J E C T I V E S
Primary objective
The primary objective of the review is to estimate the extent to
which presentation of visual images of potential health risks or
adverse consequences associated with health behaviours may in-
crease or decrease health behaviour such as:
• dietary behaviour;
• physical activity;
• smoking;
• alcohol consumption;
• sun protection behaviour;
• adherence to medical advice or treatment;
• use of health services, e.g. attendance for screening or
treatment programmes.
This will be considered in comparison to the impact of commu-
nicating information in a way that does not involve showing the
individual such images (such as through purely written or oral
communications).
Secondary objective
A secondary objective is to determine the impact of these inter-
ventions on the following outcomes (or their moderating role in
behaviour change):
• intention or motivation to change health behaviour;
• knowledge and understanding of the disease, condition,
treatment or risk;
• attitudes toward the disease, condition, treatment or health
care;
• perceived severity of the disease or condition;
• perceived susceptibility to the disease or condition;
• self-efficacy (confidence in the ability to change behaviour);
• response efficacy (perceived effectiveness of behaviour
change with regard to health);
• emotional response e.g. fear or disgust
• psychological health of the patient, including anxiety,
depression, mood, wellbeing;
• acceptability of the intervention.
M E T H O D S
Criteria for considering studies for this review
Types of studies
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Randomised controlled trials (RCTs), cluster randomised con-
trolled trials (e.g. by community or region) or quasi-RCTs (those
without truly random assignment). We will also include con-
trolled before and after (CBA) and interrupted time series (ITS)
studies, but limited to those which meet the criteria specified by
the Cochrane Effective Practice and Organisation of Care Review
Group (EPOC) (Ryan 2009). ForCBAdesigns, thismeans that the
timing of data collection for the control and intervention groups
should be the same and that both sites should be comparable on
key characteristics i.e. with respect to demographics and interven-
tion context. For ITS designs, this means having a clearly defined
point in time when the intervention occurred and at least three
data points before and three after the intervention. The inclusion
of non-RCT designs is necessitated by the difficulty of applying
true randomised trials to studies of population-level interventions.
For example, when thinking about evaluating mass media inter-
ventions, that may comprise billboard or television advertising, it
is not feasible to randomise each individual and ensure that they
are only exposed to a specific intervention. As such, we expect a
small number of eligible RCTs.
Types of participants
Adult (18+ years old) individuals towhom the aversive visual image
is directed. Participants’ health status will not determine eligibility
but we will extract this information and report it in the description
of included studies.
Types of interventions
Interventions consist of the presentation of aversive visual images
of potential health risks or adverse consequences associated with
a health behaviour, as the sole or principal component.
Not all possible types of visual image are eligible. Images in this
context are defined as photographs or pictures, either still or mov-
ing, which are representational (i.e. recognisable from the real
world) rather than abstract in form. They are concrete representa-
tions of the body’s structure, anatomy or pathology and translate
its visual properties directly. This means that both text and graphs,
which are ways of representing equivalent information, and can be
visualised, are regarded as qualitatively different and beyond the
remit of this review. Graphs may represent an object at one level,
but do not directly translate the physical properties of that object
as if it were being visualised by the eye.
We define ’aversive’ as intending to evoke a negative emotional
response, such as fear or disgust. Where this intention is not clearly
addressed by study authors, and the aversive (or otherwise) nature
of the image used is ambiguous, we will discuss this and form a
consensus as to whether an image is aversive or not.
We will include interventions irrespective of clinical context and
means of delivery. Therefore interventions applied within primary
care, inpatient or community contexts will all be eligible for inclu-
sion, as will studies that involve delivery by individuals or through
mass-media methods (e.g. advertisements, product packaging).
Included images will not feature images of the individual being
targeted by the intervention and so we will exclude interventions
which use medical imaging techniques to image the individual in
question. Such interventions are covered in another Cochrane re-
view (Hollands 2010).
We will include complex multiple-component interventions in
which communicationof images is one of an array of interventions,
provided we can ascertain an effect-size for that component.
Acceptable comparison groups are those that either:
1. provide risk/health information communicated without the
use of images; or
2. provide no risk/health information.
Types of outcome measures
Included studies must report a behavioural outcome. All outcomes
will be measured either by means of a behavioural endpoint using
an electronic or chemical measure, or through a self-report or
questionnaire measure.
Primary outcomes
Health behaviour
Engagement in health-related behaviours that have the potential to
modify the health risk of the participant, such as, but not limited
to:
• diet;
• physical activity;
• smoking;
• alcohol consumption;
• sun protection behaviours;
• adherence to medical advice or treatment;
• use of health services (e.g. attendance for screening,
treatment programmes).
Secondary outcomes
Cognitive and emotional mediators and moderators, and addi-
tional impacts of the intervention, such as:
Health behaviour
• intention or motivation to change health behaviour
• attitudes toward the disease, condition, treatment or health
care
• perceived severity and level of risk of the disease or
condition
• perceived susceptibility to the disease or condition
• self-efficacy regarding behaviour change
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• response efficacy (perceived effectiveness of behaviour
change with regard to health)
• emotional response e.g. fear or disgust
Knowledge and understanding
• knowledge and understanding of the disease, condition,
treatment or risk
Health status and wellbeing
• psychological health of the patient, including anxiety,
depression, mood, wellbeing
Evaluation of care
• acceptability of the intervention
Treatment outcomes
• adverse events reported (e.g. clinical levels of depression or
anxiety)
Service delivery level
• costs associated with featured interventions
Search methods for identification of studies
Electronic searches
We will search the following databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library) (latest issue)
• MEDLINE (OVID SP) (1950 to present)
• EMBASE (OVID SP) (1980 to present)
• CINAHL (EBSCO Host) (1982 to present)
• PsycINFO (OVID SP) (1806 to present)
The search strategies will comprise searches both for keywords and
medical subject headings under existing database organisational
schemes. We present the strategy for MEDLINE (Ovid SP) in
Appendix 1.
We will search the ProQuest Dissertations and Theses database
for grey literature.
We will search databases in the metaRegister of Randomised Con-
trolled Trials to identify ongoing studies. If applicable, we will
present relevant ongoing studies in a table in the review.
Searching other resources
We will attempt to contact authors of all included studies (along
with other key researchers in the field) to identify other studies, and
to ascertain further details of methodology and data of included
studies.
We will search reference lists of relevant studies and systematic
reviews. We will not handsearch journals.
Data collection and analysis
Selection of studies
Two review authors will independently pre-screen all search results
(titles and abstracts) for possible inclusion, and those selected by
either or both authors will be subject to full-text assessment. Two
review authors will independently assess the full-text articles for
inclusion. Any discrepancies will be resolved by consensus, over-
seen by a third review author acting as arbiter, with approval by
one review author and the arbiter being sufficient. We will list
those studies excluded after full-text assessment in the table ’Char-
acteristics of Excluded Studies’, giving reasons for exclusion.
Data extraction and management
We will develop a data extraction form based on the Cochrane
Consumers and Communication Review Group’s template, and
pilot and amend it as necessary.We will extract the following main
sets of data from each included study:
• lead author;
• date;
• study participant inclusion criteria;
• participants (participant condition(s) and demographics:
race/ethnicity, gender, religion/culture, socioeconomic status,
age);
• study design and timetable; randomisation; allocation
concealment;
• interventions (content and format of interventions,
including details of oral or written information provided; nature
of images shown to participants; intervention setting and
delivery provider; delivery of any co-interventions, theoretical
basis of intervention if stated);
• numbers of participants in each trial arm;
• outcome measures; time(s) at which outcomes assessed;
• results;
• confounders;
• analysis methods;
• additional comments.
At least two review authors will extract data independently to the
data extraction form. The forms will then be checked by a third
review author and any errors or inconsistencies resolved. The first
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review authorwill enter the data intoRevMan,with another review
author checking the accuracy of the entered data.
Assessment of risk of bias in included studies
For RCTs, cluster-randomised trials and CBA designs, we will as-
sess and report on the risk of bias of included studies by outcome,
in accordance with the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2009), which rec-
ommends the explicit reporting of the following individual do-
mains:
• sequence generation;
• allocation concealment;
• blinding of study personnel, data analysts and outcome
assessors (assessed for each main outcome or class of outcome);
• incomplete outcome data (assessed for each main outcome
or class of outcome);
• selective outcome reporting;
• other sources of bias (comparability of group characteristics,
suitability of control group in terms of contact/intervention
received).
We will also examine and report the following:
• validation and reliability of outcome measures;
• whether the study obtained ethics committee approval and
ensured informed consent for participation;
• consistency in intervention delivery (i.e. was the
information standardised/scripted and was fidelity to protocol
monitored).
In line with the Cochrane Handbook (Higgins 2009) and addi-
tional EPOC guidance (EPOC 2009) specific considerations will
be applied to ITS designs. For these studies, we will assess risk of
bias associated with the following seven domains: the intervention
being independent of other changes; the shape of the intervention
effect being pre-specified; the intervention being unlikely to af-
fect data collection; blinding of outcome assessors to intervention
allocation; incomplete outcome data being adequately addressed;
selective reporting of outcomes; and other sources of bias.
Two review authors will independently assess the risk of bias in
included studies, with any disagreements resolved by discussion
and consensus, and with a third review author acting as arbiter.
We will use the aforementioned criteria to judge whether a study
has a low, high or unclear risk of bias for each criterion. We will
present our assessment in risk of bias tables for each included study
including a descriptive summary of our decision.
We will use the GRADE system to assess the quality of the evi-
dence for each individual outcome across studies and to produce
a Summary of Findings table (Higgins 2009).
We will contact study authors for additional information about
their study methods, as necessary.
Measures of treatment effect
We will present studies’ major characteristics and results, present-
ing each primary outcome (health behaviour) separately. This will
include baseline and follow-up summary statistics and effect size
estimates and statistical significance. For ITS designs, summary
statistics will be given, and we intend to report both the change
in level of the outcome at the first time point following the intro-
duction of the intervention, and the difference in the slopes for
the levels of outcomes pre and post-intervention (i.e. post-inter-
vention slope minus pre-intervention slope). These estimates are
calculated from regression models adjusting for autocorrelation.
For continuous outcomes, measures will be standardised to have
common effect sizes, defined as the standardised mean difference
(SMD). The effect measure for dichotomous outcomes will be the
risk ratio (RR). Where varying length follow-up data are reported,
wewill report results taken from the furthest points in time relative
to the intervention.
Unit of analysis issues
The results of cluster-randomised trials, quasi-randomised trials
and CBA designs in which individual participants are allocated in
clusters to intervention groups, should account for correlation of
measurements within clusters. If an analysis is reported that ac-
counts for this element of the design, the effect will be estimated
on this basis. If this is not reported or the information is not avail-
able from authors, then an ’approximately correct’ analysis will be
carried out according to current guidelines (Higgins 2009). We
will impute estimates of the intra-cluster correlation (ICC), using
estimates derived from similar studies (Ukoumunne 1999), other
studies included in the review (if possible), or by using general
recommendations from empirical research (Campbell 2000). We
will report details of any such procedures. If this is not possible,
we will give the effect estimate as presented but report the unit of
analysis error.
Dealing with missing data
We will conduct intention-to-treat (ITT) analyses accounting for
missing data where possible, either using ITT data as provided
by study authors or, for dichotomous outcomes when ITT data
are not provided, taking a conservative approach, with the as-
sumption that drop-out implies the incidence of risk-increasing
behaviour. For example, for smoking cessation outcomes we will
follow the principle that missing data are usually regarded as ’con-
tinued smoking’. When ITT is not possible, either due to miss-
ing data, or when the outcomes are reported as continuous data,
due to the problematic nature of imputation we will analyse out-
comes as reported. We will also report on levels of drop out in
the intervention and comparison groups as an indicator of ’ac-
ceptability’ of the intervention, and the likelihood of bias due to
attrition. When summary statistics are unavailable from reports
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and through contact with authors, we will attempt to derive these
from the manipulation of reported data. Any imputation will be
explicitly reported.
Assessment of heterogeneity
We will examine heterogeneity by inspecting overlapping confi-
dence intervals (CIs) and further quantify this using the I2 statis-
tic (which describes the percentage of the variability in effect esti-
mates that is due to heterogeneity rather than to sampling error). A
value greater than 50% will be considered to represent substantial
inconsistency in findings (Higgins 2009). We intend to assess any
contribution from outliers without overlapping CIs.
Assessment of reporting biases
We will assess for small study effects using funnel plots to infor-
mally examine any relationship between study size and effect size
(Sutton 2000).
Data synthesis
We will describe and summarise the findings of the included stud-
ies. If studies that assess a given behaviour are sufficiently similar in
terms of population, inclusion criteria, interventions and/or out-
comes (including the time(s) at which these are assessed), we will
consider pooling the data relating to individual behavioural out-
comes using meta-analytic methods. We will only conduct meta-
analyses on results of RCTs and cluster RCTs deemed to be at low
risk of bias. Studies will be judged as being at a low risk of bias if
they meet all of the key criteria previously outlined (i.e. relating
to sequence generation, allocation concealment, blinding of study
personnel, incomplete outcome data, selective outcome reporting
and comparability and suitability of control group). Other studies,
if included in the review, will be tabulated in a form additional
to the meta-analyses, the findings described, summarised and in-
cluded in the Discussion.
In studies that report multiple time points for outcome measure-
ment, we will report the longest follow-up time. If multiple out-
comes are reported for a given behaviour, we will select the pri-
mary outcome that is indicated in the trial report. If this is not
indicated, we will select that which we agree to have the greatest
clinical importance.
We will use a random-effects model for pooled analysis to obtain
a pooled effect size with a 95% confidence interval (CI), reflect-
ing the heterogeneity likely to arise from the use of different set-
tings, participant groups, disease areas, interventions andmeasures
across the studies. The random-effects method and the fixed-effect
method will give identical results when there is no heterogeneity
among the studies. Where there is heterogeneity, CIs for the aver-
age intervention effect will be wider if the random-effects method
is used rather than the fixed-effect method, and corresponding
claims of statistical significance will be more conservative.
We will use Mantel-Haenszel meta-analytic methods (Mantel
1959) to analyse dichotomous outcomes. These are the default
methods in the Review Manager software to be used in the anal-
ysis (Cochrane Collaboration 2008), and are considered the most
appropriate when data are sparse, either in terms of event rates
being low or study size being small (Higgins 2009). In such cases,
the estimates of the standard errors of the effect that are used in
inverse variance methods may be poor. We will use inverse vari-
ance methods to analyse continuous outcomes.
Subgroup analysis and investigation of heterogeneity
The included studies are likely to be heterogeneous in terms of the
health risks being communicated and the behaviours that could
reduce these risks. We also expect that there will be a range of
settings in which these interventions will be used.Wewill consider
this heterogeneity when evaluating the review’s results, but do not
anticipate undertaking a formal subgroup analysis because it is
unlikely that enough readily-grouped studies will be found, and
because of the lack of a clear clinical or theoretical imperative for
such analysis. If subgroups which allow for the investigation of
interesting or important questions with a strong rationale become
clearly apparent during the review process, well-specified subgroup
analysis may be considered in future updates of the review.
Sensitivity analysis
We will undertake sensitivity analysis to examine the impact of
missing data, comparing results following ITT analysis to data ac-
tually found, and reporting if there are any significant differences.
For meta-analysis of effects on primary outcomes we will use sen-
sitivity analysis to examine how the pooled intervention effect is
affected by the inclusion of trials determined to be at unclear or
high risk of bias (as defined in Data synthesis). Finally, we will
undertake an analysis to examine whether the intervention effect
is significantly affected by our imputation of assumed ICCs.
Consumer input
For systematic reviews to be relevant to policy and practice, poten-
tial users of the review should be involved in the process. This in-
volvement can help ensure that questions pertinent to these groups
are addressed and that a range of outcomes are included. Further-
more, this may encourage review authors to present their findings
in an accessible way. This protocol and the subsequent review will
be peer reviewed by at least one consumer, as part of the Cochrane
Consumer and Communication Review Group’s standard edito-
rial process. We will also seek additional feedback from members
of the Cochrane Consumer Network at draft review stage.
A C K N OW L E D G E M E N T S
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid SP) search strategy
1. visual perception/
2. photography/
3. medical illustration/
4. audiovisual aids/
5. television/
6. motion pictures as topic/
7. exp video recording/
8. multimedia/
9. photic stimulation/
10. (image* or pictur* or pictorial or illustrat* or cartoon* or graphic* or photograph* or appearance* or animation* or film* or video*
or dvd* or cd-rom* or television or multimedia or multi-media or (visual adj (aid* or presentation or representation* or perception* or
communication* or information or media or display* or stimuli))).tw.
11. or/1-10
12. health education/
13. patient education as topic/
14. computer assisted instruction/
15. health promotion/
16. exp marketing/
17. communication/
18. persuasive communication/
19. information dissemination/
20. (health adj (communication* or information or message* or education or promotion)).tw.
21. (risk communication or health warning* or warning message*).tw.
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22. aversive therapy/
23. avoidance learning/
24. ((fear or threat) adj2 (appeal* or arous*)).tw.
25. product labeling/
26. product packaging/
27. ((modif* or chang*) adj2 (behavio* or attitud*)).tw.
28. or/12-27
29. 11 and 28
30. (aversi* or negative* or affective or threat* or danger* or disgust* or distaste* or disturbing or unpleasant* or unattractive or repel*
or repuls* or repugnan*).tw.
31. (conditioning or emotion* or fear* or warn* or risk* or motivat* or persua*).mp.
32. 30 or 31
33. 29 and 32
34. randomized controlled trial.pt.
35. controlled clinical trial.pt.
36. clinical trial.pt.
37. evaluation studies.pt.
38. comparative study.pt.
39. random*.tw.
40. placebo*.tw.
41. trial.tw.
42. research design/
43. follow up studies/
44. prospective studies/
45. cross over studies/
46. (experiment* or intervention*).tw.
47. (pre test or pretest or post test or posttest).tw.
48. (preintervention or postintervention).tw.
49. time series.tw.
50. (cross over or crossover or factorial* or latin square).tw.
51. (assign* or allocat* or volunteer*).tw.
52. (control* or compar* or prospectiv*).tw.
53. (impact* or effect? or chang* or evaluat*).tw.
54. or/34-53
55. exp animals/ not humans.sh.
56. 54 not 55
57. 33 and 56
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